Didivir 200 mg / 300 mg FC tablets
PDF Leaflet Revision Date: 13 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infections and pre-exposure prophylaxis (PrEP) in HIV-negative adults.
Dosage (summary)
One tablet daily for adults.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; avoid breastfeeding due to potential HIV transmission.
Key Drug Interactions
- Nephrotoxic medications
- Ledipasvir/sofosbuvir
Contraindications
- Hypersensitivity to components
- Creatinine clearance < 60 mL/min for PrEP
- Creatinine clearance < 50 mL/min for HIV treatment
- Pregnancy and breastfeeding
Common side effects
- Nausea
- Diarrhoea
- Headache
- Fatigue
Counselling Points
- Adhere strictly to dosing schedule.
- Monitor for signs of lactic acidosis.
- Regular HIV testing every 3 months for PrEP users.
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Risk of hepatitis B exacerbation upon discontinuation
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
